|
Dr. Orest Blaschuk was a co-founder of Adherex Technologies Inc. and currently serves as an advisor to the Company on cadherins and other cell adhesion molecules. He is a cell biologist with particular expertise in cell adhesion molecules and an Associate Professor at McGill University. Dr. Blaschuk completed his Ph.D. at the University of Toronto in Biochemistry in 1984, where he characterized a novel cell adhesion molecule, clusterin. Dr. Blaschuk completed postdoctoral training at Princeton University and accepted a position at McGill University in 1987. Dr. Blaschuk discovered the classical cadherin cell adhesion recognition sequence, HAV. He is advisory editor of Anatomy and Embryology. Dr. Blaschuk has been a member of several granting agency panels including the Medical Research Council of Canada panel on Pathology and Morphology, the California Breast Cancer Research Program panel on Tumor Biology, and the National Cancer Institute of Canada panel on Metastasis, Tumor Biology and Growth Factors. Dr. Blaschuk has authored over 60 articles in peer-reviewed journals and is named as an inventor on more than 35 U.S. patents. His laboratory at McGill University is supported in part by Adherex. | 